Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
N. C. Desai, Amit Trivedi, Hardik Somani, Krunalsinh A. Jadeja, Darshita Vaja, Laxman Nawale, Vijay M. Khedkar & Dhiman Sarkar. (2018) Synthesis, biological evaluation, and molecular docking study of pyridine clubbed 1,3,4-oxadiazoles as potential antituberculars. Synthetic Communications 48:5, pages 524-540.
Read now
Read now
Articles from other publishers (12)
Marissa B. Guzzo, Qing Li, Hoang V. Nguyen, W. Henry Boom & Liem Nguyen. (2021) The Pup-Proteasome System Protects Mycobacteria from Antimicrobial Antifolates. Antimicrobial Agents and Chemotherapy 65:4.
Crossref
Crossref
Yasodakrishna Sajja, Sowmya Vanguru, Hanmanth Reddy Vulupala, Rajashaker Bantu, Perumal Yogeswari, Dharmarajan Sriram & Lingaiah Nagarapu. (2017) Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2- b ]pyridine-1,2,3-triazole derivatives. Bioorganic & Medicinal Chemistry Letters 27:23, pages 5119-5121.
Crossref
Crossref
Ece Baydar, Miyase Gözde Gündüz, Vagolu Siva Krishna, Rahime Şimşek, Dharmarajan Sriram, Sema Öztürk Yıldırım, Ray J. Butcher & Cihat Şafak. (2017) Synthesis, crystal structure and antimycobacterial activities of 4-indolyl-1,4-dihydropyridine derivatives possessing various ester groups. Research on Chemical Intermediates 43:12, pages 7471-7489.
Crossref
Crossref
Shan-Shan Yang, Yang-Bo Hu, Xu-De Wang, Yun-Rong Gao, Kun Li, Xian-En Zhang, Shi-Yun Chen, Tian-Yu Zhang, Jing Gu & Jiao-Yu Deng. (2017)
Deletion of
sigB
Causes Increased Sensitivity to
para
-Aminosalicylic Acid and Sulfamethoxazole in Mycobacterium tuberculosis
. Antimicrobial Agents and Chemotherapy 61:10.
Crossref
Crossref
Yasodakrishna Sajja, Sowmya Vanguru, Hanmanth Reddy Vulupala, Lingaiah Nagarapu, Yogeswari Perumal, Dharmarajan Sriram & Jagadeesh Babu Nanubolu. (2017)
Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-
b
]pyridine-1,3,4-oxadiazole derivatives
. Chemical Biology & Drug Design 90:4, pages 496-500.
Crossref
Crossref
N.C. Desai, A.R. Trivedi & Vijay M. Khedkar. (2016) Preparation, biological evaluation and molecular docking study of imidazolyl dihydropyrimidines as potential Mycobacterium tuberculosis dihydrofolate reductase inhibitors. Bioorganic & Medicinal Chemistry Letters 26:16, pages 4030-4035.
Crossref
Crossref
Liem Nguyen. (2016) Antibiotic resistance mechanisms in M. tuberculosis: an update. Archives of Toxicology 90:7, pages 1585-1604.
Crossref
Crossref
N. C. Desai, A. R. Trivedi, H. V. Vaghani, H. C. Somani & K. A. Bhatt. (2015) Synthesis and biological evaluation of 1,3,4-oxadiazole bearing dihydropyrimidines as potential antitubercular agents. Medicinal Chemistry Research 25:2, pages 329-338.
Crossref
Crossref
Nisheeth C. Desai, Amit R. Trivedi, Hardik C. Somani & Kandarp A. Bhatt. (2015) Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents. Chemical Biology & Drug Design 86:3, pages 370-377.
Crossref
Crossref
Narender Reddy Emmadi, Chiranjeevi Bingi, Sudha Sravanti Kotapalli, Ramesh Ummanni, Jagadeesh Babu Nanubolu & Krishnaiah Atmakur. (2015) Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents. Bioorganic & Medicinal Chemistry Letters 25:15, pages 2918-2922.
Crossref
Crossref
Arif B. Siddiqui, Amit R. Trivedi, Vipul B. Kataria & Viresh H. Shah. (2014) 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents. Bioorganic & Medicinal Chemistry Letters 24:6, pages 1493-1495.
Crossref
Crossref
Thirumal Yempala, Jonnalagadda Padma Sridevi, Perumal Yogeeswari, Dharmarajan Sriram & Srinivas Kantevari. (2014) Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry 71, pages 160-167.
Crossref
Crossref